Literature DB >> 18265419

Bone regenerative properties of injectable PGLA-CaP composite with TGF-beta1 in a rat augmentation model.

Adelina Plachokova1, Dennis Link, Juliette van den Dolder, Jeroen van den Beucken, John Jansen.   

Abstract

The aim of this study was to examine the bone augmentation properties of an injectable composite consisting of PLGA microspheres/CaP cement (20/80), and the additional effect of loading PLGA microspheres with TGF-beta1 (200 ng). For this purpose, PLGA/CaP composites (control) and PLGA/CaP composites loaded with TGF-beta1 (test group) were injected on top of the skulls of 24 Wistar rats. Each rat received 2 materials from the same experimental group, and in total 48 implants were placed (n = 8). After 2, 4, and 8 weeks the results were evaluated histologically and histomorphometrically. The contact length between the implants and newly formed bone increased in time, and was significantly higher for the TGF-beta1-loaded composites after 2 weeks. Also, bone formation was significantly higher for the TGF-beta1-loaded composites (18.5% +/- 3) compared to controls (7.21% +/- 5) after 8 weeks of implantation. Immunohistochemical staining demonstrated massive inflammatory infiltrates in both groups, particularly at 2 weeks, which decreased substantially at 4 and 8 weeks. In conclusion, injectable PLGA/CaP composites stimulated bone augmentation in a rat model. The addition of TGF-beta1 to the composite significantly increased bone contact at 2 weeks and enhanced new bone formation at 8 weeks.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18265419     DOI: 10.1002/term.59

Source DB:  PubMed          Journal:  J Tissue Eng Regen Med        ISSN: 1932-6254            Impact factor:   3.963


  9 in total

1.  Mechanisms of endothelial cell attachment, proliferation, and differentiation on 4 types of platinum-based endovascular coils.

Authors:  Aditya S Pandey; James D San Antonio; Sankar Addya; Saul Surrey; Paolo Fortina; Elisabeth J Van Bockstaele; Erol Veznedaroglu
Journal:  World Neurosurg       Date:  2013-08-30       Impact factor: 2.104

Review 2.  Nanostructured platforms for the sustained and local delivery of antibiotics in the treatment of osteomyelitis.

Authors:  Vuk Uskokovic
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2015       Impact factor: 4.889

Review 3.  Biocomposites and hybrid biomaterials based on calcium orthophosphates.

Authors:  Sergey V Dorozhkin
Journal:  Biomatter       Date:  2011 Jul-Sep

4.  Osteogenic and antimicrobial nanoparticulate calcium phosphate and poly-(D,L-lactide-co-glycolide) powders for the treatment of osteomyelitis.

Authors:  Vuk Uskoković; Charles Hoover; Marija Vukomanović; Dragan P Uskoković; Tejal A Desai
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2013-04-13       Impact factor: 7.328

Review 5.  Nanoparticulate drug delivery platforms for advancing bone infection therapies.

Authors:  Vuk Uskoković; Tejal A Desai
Journal:  Expert Opin Drug Deliv       Date:  2014-08-11       Impact factor: 6.648

Review 6.  Calcium Orthophosphate-Containing Biocomposites and Hybrid Biomaterials for Biomedical Applications.

Authors:  Sergey V Dorozhkin
Journal:  J Funct Biomater       Date:  2015-08-07

7.  Effects of hydroxyapatite@poly-lactide-co-glycolide nanoparticles combined with Pb and Cd on liver and kidney parenchyma after the reconstruction of mandibular bone defects.

Authors:  Nenad L Ignjatović; Radmila Janković; Vuk Uskoković; Dragan P Uskoković
Journal:  Toxicol Res (Camb)       Date:  2019-02-05       Impact factor: 3.524

8.  Regeneration of the periodontium using enamel matrix derivative in combination with an injectable bone cement.

Authors:  Daniël A W Oortgiesen; Gert J Meijer; Antonius L J J Bronckers; X Frank Walboomers; John A Jansen
Journal:  Clin Oral Investig       Date:  2012-05-03       Impact factor: 3.573

9.  Poly(lactic-co-glycolic acid)-bioactive glass composites as nanoporous scaffolds for bone tissue engineering: In vitro and in vivo studies.

Authors:  Liuqing Yang; Shuying Liu; Wei Fang; Jun Chen; Yu Chen
Journal:  Exp Ther Med       Date:  2019-10-23       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.